---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-024034"
form_type: "8-K"
ticker: "SNWV"
cik: "0001417663"
company_name: "SANUWAVE Health, Inc."
filed_at: "2025-05-09T23:59:59+00:00"
generated_at: "2026-05-22T01:33:40.572497+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.78
calibrated_materiality_score: 0.78
confidence: "high"
source: SEC EDGAR
---

# Sanuwave Q1 revenue $9.34M (+61% YoY); operating income $1.0M; Q2 guidance 40-50% growth

## Summary
- Revenue $9.34M, up 61% from $5.79M in Q1 2024; gross margin 79.0% vs 72.6%; GAAP operating income $1.0M.
- Adjusted EBITDA $2.3M vs -$59k in Q1 2024; net loss $5.7M driven by change in fair value of derivative liabilities.
- UltraMist systems sold: 98 (128% increase from 43); consumables revenue +43% to $5.8M.
- Q2 2025 revenue guidance $10.0-10.7M (40-50% YoY); full year 2025 guidance reaffirmed at $48-50M.
- CEO highlights strong pipeline, comfortable inventory levels for larger customer engagements.

## SEC filing metadata
- accession: 0001628280-25-024034
- form_type: 8-K
- ticker: SNWV
- cik: 0001417663
- company_name: SANUWAVE Health, Inc.
- filed_at: 2025-05-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.78
- calibrated_materiality_score: 0.78
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417663/000162828025024034/0001628280-25-024034-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417663/000162828025024034/snwv-20250509.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-024034
- JSON: https://secwatch.observer/filing/0001628280-25-024034.json
- Plain text: https://secwatch.observer/filing/0001628280-25-024034.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.